Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
630.00    30.00 (5.00%)
Bid:
626.00
Ask:
634.00
Spread: 8.00 (1.278%)
Market Cap: £762.36m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

BLOCK LISTING RETURN

1 Jul 2024 11:24

RNS Number : 6149U
Oxford Biomedica PLC
01 July 2024
 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 January 2024

To:

30 June 2024

Balance of unallotted securities under scheme(s) from previous return:

306,521

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

11,802

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

294,719

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

1 January 2024

To:

30 June 2024

Balance of unallotted securities under scheme(s) from previous return:

250,368

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

250,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

107,069

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

393,299

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

1 January 2024

To:

30 June 2024

Balance of unallotted securities under scheme(s) from previous return:

268,072

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

50,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

31,281

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

286,791

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 January 2024

To:

30 June 2024

Balance of unallotted securities under scheme(s) from previous return:

339,753

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

NIL

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

339,753

 

Name of contact:

Natalie Walter, Company Secretary

Telephone number of contact:

01865 783000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRRBMMTMTTMBJI
Date   Source Headline
25th Mar 20225:15 pmRNSHolding(s) in Company
21st Mar 202210:44 amRNSLong Term Incentive Plan Option Grant
15th Mar 202211:25 amRNSHolding(s) in Company
15th Mar 20229:39 amRNSHolding(s) in Company
11th Mar 20224:51 pmRNSHolding(s) in Company
11th Mar 20229:01 amRNSAdmission of Conditional Placing Shares
10th Mar 20225:32 pmRNSCompletion of Transaction
9th Mar 202211:42 amRNSDirector Declaration
8th Mar 20223:54 pmRNSResult of General Meeting
1st Mar 20229:52 amRNSTotal Voting Rights
16th Feb 202211:41 amRNSPublication of Circular & Notice of GM
4th Feb 20228:22 amRNSAdmission of Firm Placing Shares
1st Feb 20229:06 amRNSTotal Voting Rights
1st Feb 20227:00 amRNSUpdate to agreement with Sio Gene Therapies
31st Jan 202211:21 amRNSMarket Share Purchase
28th Jan 20225:59 pmRNSResult of Placing and PrimaryBid offer
28th Jan 20222:04 pmRNSHoldings in Company
28th Jan 20227:38 amRNSRetail offer by PrimaryBid
28th Jan 20227:24 amRNSUS Agreement and Proposed Placing of Shares
17th Jan 20227:00 amRNSJohn Dawson to retire from Oxford Biomedica
5th Jan 20227:00 amRNSOxford Biomedica Agreement with Cabaletta Bio
4th Jan 202211:07 amRNSBlock listing Return
4th Jan 202210:32 amRNSTotal Voting Rights
4th Jan 20227:00 amRNSJohn Dawson awarded CBE in New Year Honours List
14th Dec 20217:00 amRNSBoard Appointment
13th Dec 20217:00 amRNSOxford Biomedica Updates Lentiviral Agreement
13th Dec 20217:00 amRNSOxford Biomedica Signs Agreement with Arcellx
1st Dec 20219:49 amRNSTotal Voting Rights
1st Nov 202110:08 amRNSLong Term Incentive Plan Option Grant
1st Nov 202110:02 amRNSTotal Voting Rights
19th Oct 20217:00 amRNSBoehringer Ingelheim Exercises Option
1st Oct 20219:51 amRNSTotal Voting Rights
29th Sep 20215:54 pmRNSHolding(s) in Company
29th Sep 20215:36 pmRNSDirectors Dealings / Market Share Purchases
28th Sep 20214:48 pmRNSHolding(s) in Company
28th Sep 202110:01 amRNSTotal Voting Rights
22nd Sep 20217:38 amRNSStrategic investment by Serum Life Sciences
22nd Sep 20217:00 amRNSInterim Results
1st Sep 202110:48 amRNSTotal Voting Rights
1st Sep 20217:00 amRNSNotice of Interim Results
3rd Aug 20212:20 pmRNSLTIP Option Grant
2nd Aug 202111:16 amRNSTotal Voting Rights
15th Jul 20217:00 amRNSNon-Executive Director Appointment
6th Jul 20213:10 pmRNSDirector/PDMR Shareholding
1st Jul 202111:35 amRNSBlock listing Return
1st Jul 202110:43 amRNSTotal Voting Rights
24th Jun 20211:05 pmRNSDirectors Dealings / Market Share Purchases
9th Jun 202110:36 amRNSHolding(s) in Company
8th Jun 20212:32 pmRNSGrant of options
1st Jun 202110:13 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.